Peviva
PEVIVA was established in 2000, having been granted exclusive rights to a unique apoptosis marker for cytokeratin 18 (CK18) expressing cells of epithelial origin. We strive to continuously acquire and...load more
Peviva's Basic Information
Peviva's Competitors
Employee Insights
Frequently Asked Questions Regarding Peviva
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts